Webcast Alert: Biophan Technologies to Present at Trilogy Capital's Emerging Growth Microcap Stocks Forum to be Webcast on Frida
November 18 2003 - 9:22AM
PR Newswire (US)
Webcast Alert: Biophan Technologies to Present at Trilogy Capital's
Emerging Growth Microcap Stocks Forum to be Webcast on Friday,
November 21, 2003, 12 pm ET by Informed Investors ROCHESTER, N.Y.,
Nov. 18 /PRNewswire/ -- Biophan Technologies (BULLETIN BOARD:
BIPH.OB) will webcast the following presentation: What: Biophan
Technologies (OTC:BIPH.OB) (BULLETIN BOARD: BIPH.OB) will give a
presentation at Trilogy Capital's Emerging Growth Microcap Stocks
Forum When: November 21, 2003 @ 12:00 PM Eastern Time Where:
http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339
How: Live over the Internet -- Simply log on to the web at the
address above. Contact: AJ Cervantes, Trilogy Capital, ,
800-330-1860 If you are unable to participate during the live
webcast, the call will be available for replay at
http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339.
Biophan, a highly innovative company, is developing technology that
makes biomedical devices safe and reduces the interference that
these devices cause to Magnetic Resonance Imaging (MRI) image
quality. Today, many devices (such as pacemakers and surgical
devices) are not used with MRI due to safety concerns involved with
the MRI environment, including heating of devices and metal wire
leads, which can cause tissue damage. Most MRI imaging centers
today refuse to allow pacemaker patients and those with other
implanted medical devices to undergo MRI imaging due to safety
concerns. In order to make the most effective use of MRI (in
addition to resolving the safety concerns) it is desirable that the
device not interfere with the MRI image quality. Biophan's
solutions also address this objective. MRI is one of the most
important diagnostic tools in medicine. Biophan currently has 42
patents pending on this technology and exclusive licenses for three
issued U.S. patents. For more information, visit the Company's
website at http://www.biophan.com/. FORUM CONTACT: Janet Scharr,
Informed Investors, 804-327-3424, DATASOURCE: Biophan Technologies,
Inc. CONTACT: AJ Cervantes of Trilogy Capital, +1-800-330-1860, ;
or Janet Scharr of Informed Investors, +1-804-327-3424, Web site:
http://www.biophan.com/ http://www.informedinvestors.com/
Copyright